cvs - anti-clotting drugs Flashcards
name 4 antiplatelet drugs
- NSAIDs
- platelet GPIIB/IIA receptor blockers
- ADP receptor blockers
- PDE inhibitors
moa of aspirin
inhibit COX-1 → reduce thromboxane A2 and inhibit platelet aggregation
clinical uses of aspirin
- prophylaxis for transient cerebral ischemia
- reduce incidence of recurrent MI
- decrease mortality post-MI
adverse effects of aspirin
- bleeding
- gastric upset and ulcers (due to reduced PGE2)
- reye’s syndrome
name 3 platelet GP IIB/IIA receptor blockers
- abciximab
- eptifibatide
- tirofiban
moa of platelet GP IIB/IIA receptor blockers
prevent fibrinogen binding and inhibit platelet aggregation
clinical uses of platelet GP IIB/IIA receptor blockers
- prevent stenosis after coronary angioplasty
- acute coronary syndromes
adverse effects of platelet GP IIB/IIA receptor blockers
- thrombocytopenia
- bleeding
name 2 ADP receptor blockers
- clopidogrel
- ticlopidine
moa of ADP receptor blockers
irreversibly block ADP receptors on platelets, inhibiting activation
name 1 PDE inhibitor
dipyridamole
moa of PDE inhibitor
inhibit PDE → prevent breakdown of cAMP to 5’-AMP → increased cAMP → inhibit platelet aggregation
name 4 anticoagulants
- heparin derivatives
- coumarin derivatives
- lepirudin/hirudin
- antithrombin III
moa of heparin
- bind to AT III and IIa → allows AT III to get close to IIa to deactivate it
- once heparin binds to AT III, it can deactivate Xa wo binding to it
- LMWH increases action of AT III on factor Xa (but not on thrombin)
clinical use of heparin
- dvt
- pulm embolism
- acute MI
- anticoagulant for pregnancy
how should heparin be administered
IV/SC
why can’t heparin be given IM
haematomas
adverse effects of heparin
- haemorrhage
- thrombocytopenia
- osteoporosis w LT use
how to treat haemorrhage due to heparin use
stop heparin + start protamine sulfate (binds to excess heparin)
moa of warfarin
vit k reductase inhibitor → inhibit vit K-dep clotting factors (II, VII, IX, X)
clinical uses of warfarin
- dvt
- pulm embolism
- acute MI
adverse effects of warfarin
- bleeding
- DDI (CYP450)
contraindications for warfarin
pregnancy (causes haemorrhagic disorders in foetus, foetal proteins w gamma-carboxyglutamate residues affected)
moa of lepirudin
directly inhibits thrombin
moa of antithrombin III
enhance inactivation of thrombin and other coagulation enzymes
name 4 thrombolytics
- t-PA
- urokinase
- streptokinase
- anistreplase
moa of thrombolytics
directly converts plasminogen to plasmin → clot breakdown
clinical uses of thrombolytics
- emergency treatment of coronary artery thrombosis
- peripheral arterial thrombosis and emboli
- ischaemic stroke
adverse effect of thrombolytics
bleeding
contraindications for thrombolytics
- recent surgery
- bleeding disorders
- severe uncontrolled hypertension
- pregnancy
moa of t-PA
binds to fibrin in a thrombus and converts plasminogen to plasmin → clot breakdown
clinical use of t-PA
dissolve blood clots in MI/stroke
clinical use of urokinase
- severe dvt
- pulm embolism